Clinical Trial Update: Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluates methotrexate, cyclophosphamide, and etoposide phosphate with osmotic blood-brain barrier disruption plus dexamethasone and cytarabine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYTARABINE (CYTARABINE)
• DEXAMETHASONE (Dexamethasone)
• Etoposide phosphate (etoposide phosphate)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Lymphoma | Phase 2 | Status: COMPLETED